We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
Trades about 116% below its sector, cheaper than its peers on earnings.
Zenlabs Ethica Limited operates as a pharmaceutical firm specializing in the commerce of medicinal goods. Its extensive product range covers numerous therapeutic categories, including but not limited to pain management and anti-inflammatory drugs, dermatological applications, treatments for neurological disorders, specialized ear, eye, and nasal drops, anti-diabetic and antidepressant medications, antivirals, anti-emetics, various steroids, antihypertensive compounds, anti-allergy and cold remedies, cough syrups, nutritional supplements, digestive aids such as antacids and enzymes, appetite stimulants, traditional Ayurvedic formulations, and solutions for gastrointestinal ailments. The company was founded on July 20, 1993, and maintains its headquarters in Chandigarh, India.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save ZENLABS.BO and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
